Review article: Platelet abnormalities in diabetes mellitus
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Patients with diabetes mellitus (DM) have accelerated atherosclerosis, which is the main underlying factor contributing to the high risk of atherothrombotic events in these patients. Atherothrombotic complications are the leading cause of morbidity and mortality in patients with DM. Among factors contributing to the prothrombotic condition which characterise patients with DM, platelet hyperreactivity plays a pivotal role. Platelets of DM patients are characterised by dysregulation of several signalling pathways leading to intensified adhesion, activation and aggregation. Multiple mechanisms are involved in platelet dysfunction of patients with DM, which can be categorised as follows: a) hyperglycaemia, b) insulin deficiency and resistance, c) associated metabolic conditions, and d) other cellular abnormalities.The present manuscript aims to provide an overview on the current status of knowledge on platelet abnormalities that characterise patients with DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888 · cited 1×
“5 years of followup due to an increased mortality in the intensive therapy group.(28) The latter is in line with the results of the NICESUGAR (Normoglycemia in Intensive Care Evaluation– Survival Using Glucose Algorithm Regulation) trial that randomised patients admitted to an intensive care unit to undergo either int…”
ResultHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“0 mmol/l or less), in which mortality was higher in the intensive glucose control group.(29) Several mechanisms have been proposed to contribute to the increased platelet reactivity caused by hyperglycaemia, including the following: a) non-enzymatic glycation of platelet membrane proteins that decreases membrane fluid…”
BackgroundNormalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · cited 1×
“An increase in reactive oxygen species in addition to chronic hyperglycaemia enhances production of advanced glycation end products (AGEs).(82) These glycated proteins may contribute to the development of atherosclerotic complications by activation of the receptor for AGEs (RAGE)(83) and by enhancing platelet aggregat…”
BackgroundPlatelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Malmberg, K., Rydén, L., Wedel, H., Birkeland, K., Bootsma, A., Dickstein, K., Efendic, S., Fisher, M., Hamsten, A., Herlitz, J., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi199 · Cited by 1,048
Platelet activation in type 2 diabetes mellitus
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493
Large Platelets Circulate in an Activated State in Diabetes Mellitus
Tschoepe, D., Roesen, P., Esser, J., Schwippert, B., Nieuwenhuis, H., Kehrel, B., & Gries, F. (1991) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002650 · Cited by 266 · cited 1×
“In addition, platelets of DM patients are larger, and thus hyperreactive, as platelet size correlates with greater platelet reactivity measured by aggregation and total release of granular content.(92)”
BackgroundEvidence for abnormal platelet glycoprotein expression in diabetes mellitus
TSCHOEPE, D., ROESEN, P., KAUFMANN, L., SCHAUSEIL, S., KEHREL, B., OSTERMANN, H., & GRIES, F. A. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb02264.x · Cited by 217
Cited by
Kaur, R., Kaur, M., & Singh, J. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0763-3 · Cited by 736
Metadata
- Authors
- Ferreiro, J. L., Gómez-Hospital, J. A., & Angiolillo, D. J.
- Venue
- Diabetes and Vascular Disease Research
- Publisher
- SAGE Publications
- Published
- 2010-10
- Volume
- 7
- Issue
- 4
- Pages
- 251-259
- ISSN
- 1479-1641 (ISSN-L)
- 1752-8984
- OpenAlex
- W2171792003
- Cited by
- 216
- References
- 13
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review article: Platelet abnormalities in diabetes mellitus. https://app.cochat.ai/papers/10.1177/1479164110383994
- The paper
- Ferreiro, J. L., Gómez-Hospital, J. A., & Angiolillo, D. J. (2010). Review article: Platelet abnormalities in diabetes mellitus. Diabetes and Vascular Disease Research. https://doi.org/10.1177/1479164110383994
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.